5 Things You Need to Know About Epilepsy & Depression
Heidi M. Munger Clary, MD, MPH
Jay Salpekar, MD, FANPA
Early Recognition and Diagnosis of Castleman Disease
Sanam Loghavi, MD
Razelle Kurzrock, MD, FACP
Revolutionizing Care for Patients With T2D and Obesity: From Pathophysiology to Personalized Treatments
Scott Kahan, MD, MPH
Ken Fujioka, MD
Carol Wysham, MD
Expanding Screening, Improving Treatment Acceptance, and Optimizing Outcomes for Patients with Moderate to Severe Alcohol Use Disorder (AUD)
Annie Levesque, MD, MSc
Ethan A. Cowan, MD
Advances in Minimally Invasive Screening for Lung Cancer: Breaking Data from Honolulu
Julie A. Barta, MD, ATSF
Peter J. Mazzone, MD, MPH, FCCP
What Are the Emerging Therapies for Managing Gout?
Richard Johnson, MD
John K. Botson, MD, RPh
The Underestimated Consequences of Uncontrolled Gout: Renal and Cardiovascular Implications
Abdul Abdellatif, MD, FASN
Brittany Weber, MD, PhD
Can You Manage Patients With Uncontrolled Gout More Effectively?
Gout Beyond the Joints: What’s the Hidden Danger?
Should We Look for Gout in the Cardiology Clinic?
Center of the Target: Which Patients Are Most Likely to Develop Gout?Â
Treat or Refer: Who Is Responsible for Managing Gout?
Is Managing Gout in the Nephrology Clinic a Challenge?
What’s New About Gout? Rheumatology PerspectiveÂ
Is Gout Hiding in the Nephrology Clinic?Â
What’s New About Gout? Nephrology Perspective
Loading...
We’re glad to see you’re enjoying Prova Education… but how about a more personalized experience?
Press cancel to remain on Prova Education. Press the link below or the continue button to keep going.